Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers (Q36233866)

12 August 2017

Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers (English)

1 reference

12 August 2017

hepatocellular carcinoma

1 reference

Jung Il Lee

1

1 reference

12 August 2017

Jin-Woo Lee

2

1 reference

12 August 2017

Joon Mee Kim

3

1 reference

12 August 2017

Ja Kyung Kim

4

1 reference

12 August 2017

Hyun Jung Chung

5

1 reference

12 August 2017

Young Soo Kim

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

World Journal of Gastroenterology

12 August 2017

1 reference

12 August 2017

18

1 reference

12 August 2017

34

1 reference

12 August 2017

4751-4757

1 reference

Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Combined hepatocellular cholangiocarcinomas; analysis of a large database

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Molecular pathology of hepatic neoplasms: classification and clinical significance

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Pathology of combined hepatocellular-cholangiocarcinoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Current strategy for staging and treatment: the BCLC update and future prospects.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Progenitor-derived hepatocellular carcinoma model in the rat.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Histopathological classification of hepatocellular carcinoma.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442214

Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior

21 October 2018

1 reference

12 December 2020

Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor

1 reference

12 December 2020

The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin

1 reference

12 December 2020

Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors

1 reference

12 December 2020

Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V18.I34.4751

1 reference

release_reccktnypneeraoawfxgkyloyq

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/reccktnypneeraoawfxgkyloyq

24 November 2022

mapped directly with Wikidata item

1 reference

12 August 2017

1 reference